Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study

Inflammatory Bowel Diseases- United States

doi 10.1097/mib.0000000000000368

Full Text

Abstract

Available in

Categories

Gastroenterology

Date

March 1, 2015

Authors

Ekaterina Safroneeva

Stephan R. Vavricka

Nicolas Fournier

Alain M. Schoepfer

Publisher

Oxford University Press (OUP)

Related search

Risk Factors for Ulcerative Colitis in Shahrekord, Iran: A Case-Control Study

International Journal of Epidemiologic Research

English

Risk Factors for Complications After Total Colectomy in Ulcerative Colitis.

Inflammatory Bowel Diseases

Gastroenterology

English

Comment On: Prospective Cohort Study of Appendicectomy for Treatment of Therapy‐refractory Ulcerative Colitis

British Journal of Surgery

English

Frequency of and Risk Factors for Depression Among Participants in the Swiss HIV Cohort Study (SHCS)

Multidisciplinary

English

Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab in Sweden

Value in Health

Occupational Health

English

167 Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

Gastroenterology

Gastroenterology

English

Risk Assessment in Acute Ulcerative Colitis

English

Author Response To: Comment On: Prospective Cohort Study of Appendicectomy for Treatment of Therapy‐refractory Ulcerative Colitis

British Journal of Surgery

English

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine

English